Andrew Scarsbrook
Leeds Teaching Hospitals NHS Trust
CancerInternal medicineRadiologyPET-CTSurgeryPathologyMagnetic resonance imagingOncologyTomographyFunctional imagingMedical physicsPositron emission tomographyLung cancerHead and neck squamous-cell carcinomaCarcinomaDiseaseMalignancyMEDLINEScintigraphyNuclear medicineIn patientFdg pet ctRadiation therapyComputed tomographyMedicine
206Publications
29H-index
2,565Citations
Publications 134
Newest
#2Petros PerrosH-Index: 57
Last. Ching-Jung HsiehH-Index: 8
view all 50 authors...
Source
#1P MalhotraH-Index: 4
Last. Andrew ScarsbrookH-Index: 29
view all 6 authors...
Background PET-CT is an important test in the management of patients with solitary pulmonary nodules (SPNs). There is a paucity of data on clinical characteristics, follow-up and outcomes of patients with PET negative nodules as compared to PET positive ones. Objective To compare the clinical characteristics and outcomes of patients with PET positive vs PET negative SPNs managed by the Lung MDT at a large teaching hospital in North England. Methods 144 patients (age range 32–92 years, 76 females...
Source
#1R.H. Briggs (Calderdale and Huddersfield NHS Foundation Trust)H-Index: 1
#2Fahmid U. Chowdhury (St James's University Hospital)H-Index: 18
Last. Andrew Scarsbrook (St James's University Hospital)H-Index: 29
view all 4 authors...
AIM: To assess the clinical impact of 2-[ 18 F]-fluoro-2-deoxy-D-glucose (FDG) positronemission tomographyecomputed tomography (PET-CT) in patients with potentially resectable metastatic colorectal cancer. MATERIALS AND METHODS: One hundred and two patients with potentially resectable metastatic colorectal cancer underwent FDG PET-CT in addition to conventional imaging over an 18-month period. The findings were compared to conventional imaging, with histological or clinico-radiological validatio...
41 CitationsSource
#1H. Lambie (Leeds Teaching Hospitals NHS Trust)H-Index: 1
#2A.M. Cook (Leeds Teaching Hospitals NHS Trust)H-Index: 1
Last. Fahmid U. Chowdhury (Leeds Teaching Hospitals NHS Trust)H-Index: 18
view all 6 authors...
There have been evolutionary changes in the management of pathological conditions of the hepatobiliary system over recent years, particularly with an increasing emphasis on modern hepatobiliary surgical techniques. Concurrent advances have occurred in imaging technology and availability, leading to a greater use of ultrasound, multidetector computed tomography (CT), and magnetic resonance imaging (MRI) in the primary evaluation of hepatobiliary disease. Radionuclide imaging using technetium 99m ...
24 CitationsSource
#1Puneet Malhotra (Leeds Teaching Hospitals NHS Trust)
#2Natasha Lovell (Leeds Teaching Hospitals NHS Trust)
Last. Matthew E.J. Callister (Leeds Teaching Hospitals NHS Trust)H-Index: 18
view all 6 authors...
Background: Management of patients with SPNs depends critically on the pre-test probability of malignancy. There are currently two clinical predictions models for SPNs based on data from North America. However, these models have not been validated in UK patients, in particular those managed by a Lung MDT. Objective: To validate two existing clinical prediction models in patients with SPNs managed by the Lung MDT at a large teaching hospital. Methods: 175 patients with SPNs measuring 8–30 mm mana...
view all 4 authors...
#2Andrew ScarsbrookH-Index: 29
view all 3 authors...
#1A. D. Culverwell (Leeds Teaching Hospitals NHS Trust)H-Index: 2
#2Andrew Scarsbrook (Leeds Teaching Hospitals NHS Trust)H-Index: 29
Last. Fahmid U. Chowdhury (Leeds Teaching Hospitals NHS Trust)H-Index: 18
view all 3 authors...
With the increasing utilization of integrated positron-emission tomography/computed tomography (PET/CT) using the glucose analogue 2-[18F]-fluoro-2-deoxy- d- glucose (FDG) in oncological imaging, it is important for radiologists and nuclear medicine physicians to be aware that FDG uptake is not specific for malignancy, as many different physiological variants and benign pathological conditions can also exhibit increased glucose metabolism. Such false-positive FDG uptake often arises outside the ...
64 CitationsSource
#2Maria SheridanH-Index: 8
Last. Ashley GuthrieH-Index: 1
view all 4 authors...
Poster: "ECR 2011 / C-1218 / Gallbladder Carcinoma: Multimodality imaging pearls and pitfalls" by: "K. Mehta1, M. Sheridan1, A. F. Scarsbrook2, A. Guthrie1; 1Leeds/UK, 2York/UK"
Poster: "ECR 2011 / C-0472 / Clinical impact of FDG PET-CT on management decisions in patients with uterine and vaginal malignancy" by: "W. W. Yap, R. Cooper, F. U. Chowdhury, A. F. Scarsbrook; Leeds/UK"